Dr. Christina Juli
Boehringer Ingelheim International GmbH Biberach an der Riss, Germany
Head of CMC, CCM RA Office NBE Dr. Christina Juli studied pharmacy at the University of Wuerzburg, Germany. After her PhD thesis in the fields of pharmaceutical chemistry, in 2012, she joined the ratiopharm GmbH in Ulm, Germany. She started her professional career as Senior Manager in the department of EU Regulatory Affairs Generic Maintenance. Since 2018, she is working in the Tech RA department at Boehringer Ingelheim Pharma GmbH & Co. KG in Biberach, Germany. In her role as Head of CMC Management CMB, she focuses on the CMC development for biologics and is responsible for the definition, compilation and review of the CMC documentation for clinical trial and new drug applications as well as for post approval submissions worldwide. Beyond that, as regulatory intelligence responsible for her business unit, she monitors the regulatory legislation, regulations, guidelines and position papers from pharmaceutical and biological industry worldwide. She is an active participant in the BioPhorum Operations Group (Post Approval Strategy and Regulatory Governance working groups).
Dr Galina Senchukova
Independent Regulatory Consultant, RUSSIA
Galina Senchukova is an expert on registration of Drug Products in Russia, EAEU and CIS non-EAEU countries. Before becoming an independent regulatory consultant, in 2017-2024 she worked as Regulatory and Quality Assurance Head at CSL Behring and in 2013-2017 - as Regulatory Head at Sanofi Pasteur in Russia. Before that she worked on different regulatory positions at Sanofi, MSD and GSK. PhD in Pharmaceutical Chemistry, advanced RA professional with about 18 years hands-on experience in Rx, biological and biotechnological products registration (blood plasma products and vaccines), mostly specializing in CMC area. Together with her local team achieved many successful registration of Drug Products in complicated and challenging regulatory environment.
Prashant Shroff
AstraZeneca Pharma India Pvt. Ltd., Begaluru, INDIA
He has worked at CDSCO (Zonal office of Indian Govt. Authority) as a Technical Data Associate. He started his professional journey in the private sector with Sun Pharmaceutical Ind. Ltd. in 2016 and then he joined Pharmalex India Pvt. Ltd. Currently, he is working as Regulatory Affairs Manager at AstraZeneca Pharma India Pvt. Ltd. In his career, he has well-versed experience for the Indian registration procedures for drug products as well biologicals covering regulatory strategy throughout the life cycle management, documentation, pharmacopoeial compliance, labelling, package inserts etc.
28/04/2026
28/04/2026
from 09:00 am until 05:00 pm CET
You may dial in 30 minutes before the training starts
online
online
Veranstaltung - 1,350 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Veranstaltung - 1,350 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Birgit Wessels
Conference Manager
+49 6221 500-652
b.wessels@forum-institut.de
CMC requirements in China, Japan, South Korea, India and Russia/EAEU. Meet our three experts to get an update on the current requirements in the different regions and discuss your individual issues with them. Contact us!
During this training you will learn about the specific CMC requirements in China, Japan/South Korea, India, and Russia/EAEU.
Three (local) experts will share valuable information regarding
The feedback of participant's from former courses:
16.09.2025 10:00 - 12:15
Dr Christina Juli
24.09.2025 10:00 - 12:15
Dr Christina Juli
30.09.2025 10:00 - 12:15
Dr Galina Senchukova
07.10.2025 10:00 - 12:15
Prashant Shroff
FORUM Institut’s all-in-one training platform uses the latest teaching methods.
All our online training courses take place in the Learning Space, our holistic learning environment with many features that promote effective and sustainable learning.
of 5 stars of all ratings from 2024
of 5 stars on Trustpilot = good
This seminar provides an in-depth exploration of EU drug marketing authorisation, focusing on regulatory frameworks, app...
To make the most of ICH Q12 opportunities, you have to be aware of the relation between ICH guidelines Q8 to Q12 and how...
Get your know-how on creating and maintaining quality data for biotech products in our online training. Including an out...
This online training will give you in-depth knowledge on the CMC requirements for marketing authorisation. Including an ...
Our global and local experts will update you every two months with the latest regulatory and legislative developments. T...
This whitepaper describes what you need to keep in mind when it comes to specific Japanese CMC requirements for marketin...
Details
More than 4,000 customers have rated our training courses. Thank you for awarding us 4.3 stars out of 5.
Details